Source: International Congress 2015 – Acute critical care: novelties in critical care
Disease area: Airway diseases, Respiratory critical care



Rating:

Share or cite this content

Citations should be made in the following way:
Jan Beute (Almere, Netherlands), Jan Beute, Menno Van Nimwegen, Ruud Hendriks, Alex Kleinjan. Enoximone as emergency medication for life threatening asthma and suppression of allergic airway inflammation as measured in a house dust mite asthma model. Eur Respir J 2015; 46: Suppl. 59, 2151

Member's Comments

No comment yet.

Related content which might interest you: Changes in symptoms, respiratory function, airway inflammation, and airway hyperresponsiveness over 10 year of inhaled corticosteroid therapy in adult asthma patients Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015 Respiratory symptoms, airway inflammation and lung function in workers at risk of occupational asthma Source: International Congress 2019 – Airway and parenchymal diseases in occupational and environmental lung diseases Year: 2019 Special problems of severe asthma in childhood Source: Eur Respir Mon 2011; 51: 59-81 Year: 2011 A new asthma severity index: a predictor of near-fatal asthma? Source: Eur Respir J 2001; 18: 272-278 Year: 2001 Treatment of acute asthma Source: Eur Respir Mon 2012; 56: 172-187 Year: 2012 The physiology of difficult childhood asthma: is it only obstruction? Source: Annual Congress 2005 - Difficult asthma in children Year: 2005 Adult asthma patients reporting exacerbations triggered by upper airway infection have increased total IgE and sensitization to HDM Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases Year: 2014 Asthma exacerbations in relation to severe asthma Source: Eur Respir Mon 2011; 51: 120-129 Year: 2011 Respiratory symptoms, atopy and bronchial hyperreactivity in professional firefighters Source: Eur Respir J 2007; 30: 538-544 Year: 2007 Blood eosinophils, exacerbations in the previous year, lung function and ICS dose predict frequent exacerbations in asthma Source: International Congress 2016 – Phenotyping asthma Year: 2016 Omalizumab therapy reduces asthma exacerbations in children with severe allergic (IgE-mediated) asthma irrespective of lung function at baseline Source: Annual Congress 2009 - Difficult asthma in children: diagnostic and therapeutic challenges Year: 2009 Severe asthma: the way forward Source: Eur Respir Mon 2011; 51: 297-308 Year: 2011 Problematic severe asthma Source: Eur Respir Mon 2012; 56: 22-39 Year: 2012 The ’real-life’ long-term efficacy of omalizumab in severe persistent IgE-mediated allergic asthma in Malta Source: International Congress 2016 – Asthma management Year: 2016 Breathing training improves asthma symptoms but not airways inflammation or hyper-reactivity in asthma Source: Annual Congress 2008 - Diagnosing, monitoring and treating respiratory diseases in primary care Year: 2008 Is there any day variability of respiratory function and airway inflammation in children with mild asthma? Source: Eur Respir J 2006; 28: Suppl. 50, 264s Year: 2006 Frequency and clinical characteristics of rapid-onset fatal and near-fatal asthma Source: Eur Respir J 2002; 19: 846-852 Year: 2002 Respiratory viral infections as promoters of allergic sensitization and asthma in animal models Source: Eur Respir J 2002; 19: 341-349 Year: 2002 Perception of bronchoconstriction is associated with the severity of asthma in children Source: Annual Congress 2005 - Monitoring paediatric asthma Year: 2005